Aemetis (AMTX) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Aemetis (NASDAQ:AMTX) from a sell rating to a hold rating in a research note published on Monday morning.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Separately, B. Riley reissued a hold rating and issued a $2.00 price objective on shares of Aemetis in a research report on Monday, November 13th.

Aemetis (NASDAQ AMTX) traded down $0.02 during mid-day trading on Monday, reaching $0.70. The company’s stock had a trading volume of 14,700 shares, compared to its average volume of 44,482. The company has a debt-to-equity ratio of -1.87, a quick ratio of 0.20 and a current ratio of 0.37. Aemetis has a twelve month low of $0.51 and a twelve month high of $2.50. The stock has a market capitalization of $14.27, a PE ratio of -0.69 and a beta of 0.69.

A hedge fund recently bought a new stake in Aemetis stock. Ninepoint Partners LP purchased a new stake in shares of Aemetis Inc (NASDAQ:AMTX) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned about 5.81% of Aemetis at the end of the most recent reporting period. 17.73% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Aemetis (AMTX) Upgraded at Zacks Investment Research” was originally posted by Week Herald and is the property of of Week Herald. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://weekherald.com/2018/01/18/aemetis-amtx-upgraded-at-zacks-investment-research.html.

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Get a free copy of the Zacks research report on Aemetis (AMTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply